YOU ARE HERE : Endocrinology and Diabetes / : graduate students : Bin Zhang, BS
Section Home
  A-Z list, faculty & staff
  Adjunct Faculty
  Clinical Fellows
  Clinical Staff
  Research Fellows / Post Docs
  Research Staff
  Graduate Students
  Administrative Staff
  Endocrinology Event Calendar
  Clinical Fellowship Program
  Research Programs
  Weekly Seminars
  Annual Meetings
  Program Grants
Harold Hamm Diabetes Center
Positions Available
Visit Oklahoma City
Visit Tulsa
Cost of Living Comparison
Bin Zhang, BS
Graduate Student

Mailing Address:
941 Stanton L. Young Blvd., BSEB 331
Oklahoma City, OK 73104

(405) 271-5896 ext 47791
(405) 271-3973


Research Interests

My dissertation work is to investigate the role of an angiogenic inhibitor in diabetic retinopathy, and further I am focusing on the Wnt signaling pathway to explain the mechanism.

In summary, SERPINA3K, an extracellular serin proteinase inhibitor, is also an antagonist of the Wnt coreceptor named LRP6. With its Wnt-inhibitory function, SERPINA3K plays important roles in attenuating abnormal angiogenesis, inflammation and fibrosis, which are major causes of vision loss in diabetic retinaopathy. It suggests a therapeutic potential of SERPINA3K in DR. SERPINA3K also displays the neurotrophic activity through the inhibition of PLC/calcium pathway, suggesting a prospect on the neuron protection study in diabetic retinaopathy.



2005-2010 PhD - University of Oklahoma Health Sciences Center, Oklahoma City, OK
1998-2003 BS - University of Science & Technology of China, Hefei, China


Recent Publications

Jenkins AJ, McBride JD, Januszewski AS, Karschimkus CS, Zhang B, O'Neal DN, Nelson CL, Chung JS, Harper CA, Lyons TJ, and Ma J-x. (2010). Increased serum Kallistatin levels in patients with Type 1 Diabetes and its vascular complications. J. Angiogenesis Res., under review.

Park K, Lee K, Zhang B, Zhou T, He X, Gao G, and Ma J-x. (2010). Identification of Pigment Epithelium-Derived Factor as a Novel LRP6 Antagonist. J. Clin. Invest., in revision.

Zhang B, Abreu JG, Zhou K, Chen Y, Hu Y, Zhou T, He X, and Ma J-x. (2010). Blocking the Wnt pathway, a unifying mechanism for an angiogenic inhibitor in the serine proteinase inhibitor family. Proc. Natl. Acad. Sci. USA, Epub ahead of print.

Zhang B, Zhou K, and Ma J-x. (2010). Inhibition of CTGF over-expression in diabetic retinopathy by SERPINA3K via blocking the WNT/beta-catenin pathway. Diabetes, Epub ahead of print.  

Zhou T, Hu Y, Chen Y, Zhou K, Zhang B, Gao G, and Ma J-x. (2009). The pathogenic role of the canonical Wnt pathway in age-related macular degeneration. Invest. Ophthalmol. Vis. Sci., Epub ahead of print.

Zhang B, Hu Y, and Ma J-x. (2009). Anti-inflammatory and antioxidant effects of SERPINA3K in the retina. Invest. Ophthalmol. Vis. Sci., 50, 3943-3952.

Zhang B, and Ma J-x. (2008). SERPINA3K prevents oxidative stress induced necrotic cell death by inhibiting calcium overload. PLoS ONE, 3, e4077.

Zhang B, Wei H, Zheng X, Zhang J, Sun R, and Tian Z. (2005). The inhibitory effects of synthetic short peptides, mimicking MICA and targeting at NKG2D receptors, on function of NK cells . Peptides, 26(3), 405-412.

TOP ^  
The University of Oklahoma Health Sciences Center

Endocrinology and Diabetes
1000 N. Lincoln Blvd.; Harold Hamm Diabetes Center Building #2900
Oklahoma City, OK 73104
Phone - (405) 271-5896
FAX - (405) 271-7522

Every effort will be made to update the information contained on these pages as necessary. However, it is the responsibility ofthe user to determine that he or she is relying on the most current version of any particular information. Any questions about the material should be directed to the referenced office or department.